Ropes Gray Reps Genzyme In $265M Diagnostics Sale
Genzyme Corp. on Thursday announced plans to sell its diagnostic products unit to Japan's Sekisui Chemical Co. Ltd. for $265 million in cash as part of the Massachusetts medical company's efforts...To view the full article, register now.
Already a subscriber? Click here to view full article